Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 88생성일: 2026년 10월 23일
(5S)-5-ethyl-1,3-oxazolidin-2-one → N'-[5-[[4-(cyanomethyl)phenyl]methyl]-4-[(5S)-5-ethyl-2-oxo-1,3-oxazolidin-3-yl]-6-methylpyrimidin-2-yl]-N,N-dimethylmethanimidamide
https://huagongshe.com/ko/reaction/88
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | (5S)-5-ethyl-1,3-oxazolidin-2-one | HCID 55286406 | — |
| 반응물 | N'-[4-chloro-5-[[4-(cyanomethyl)phenyl]methyl]-6-methylpyrimidin-2-yl]-N,N-dimethylmethanimidamide | HCID 141240178 | — |
| 시약 | Potassium Carbonate | HCID 11430 | — |
| 촉매 | 1,1'-(9,9-Dimethyl-9H-xanthene-4,5-diyl)bis(1,1-diphenylphosphine) | HCID 636044 | — |
| 촉매 | Palladium (II) acetate | HCID 4144353 | — |
| 용매 | 1,4-Dioxane | HCID 31275 | — |
| 생성물 | N'-[5-[[4-(cyanomethyl)phenyl]methyl]-4-[(5S)-5-ethyl-2-oxo-1,3-oxazolidin-3-yl]-6-methylpyrimidin-2-yl]-N,N-dimethylmethanimidamide | HCID 87445299 | 45.7% |
반응 단계
Palladium(II) acetate (8.22 mg, 0.04 mmol) and 9,9-Dimethyl-4,5-bis(diphenylphosphino)xanthene (42.4 mg, 0.07 mmol) were added to dioxane (3 mL) and the solution was stirred at room temperature for 10 minutes.(E)-N'-(4-chloro-5-(4-(cyanomethyl)benzyl)-6-methylpyrimidin-2-yl)-N,N-dimethylformimidamide (240 mg, 0.73 mmol), (S)-5-ethyloxazolidin-2-one (169 mg, 1.46 mmol) and POTASSIUM CARBONATE (202 mg, 1.46 mmol) were added and the mixture was heated at 100 °C for 1 hour. The solvent was evaporated under reduced pressure and the crude product was purified by flash silica chromatography, elution gradient 2 to 5% methanol in dichloromethane. Pure fractions were evaporated to dryness to afford (S,E)-N'-(5-(4-(cyanomethyl)benzyl)-4-(5-ethyl-2-oxooxazolidin-3-yl)-6-methylpyrimidin-2-yl)-N,N-dimethylformimidamide (136 mg, 45.7 %) as a colorless solid.
출처 및 근거
| 출처 데이터셋 | 750 AstraZeneca ELN dataset |
|---|
| ORD ID | ord-484b31bdd1aa4746881181205ba1de67 |
|---|
| 출처 메모 | 750 AstraZeneca ELN dataset |
|---|